Tech & industry

Interactive ball which replicates breathing is delivering wellbeing benefits

AI can indicate presence of the disease an average of seven years before clinical presentation

Use of brain-computer interface adds to options in at-home, remote rehab

Trousers powered by artificial intelligence have given a stroke survivor the power to learn to walk independently again. Stroke patient, Julie Lloyd, is part of the UK's first trial of the NeuroSkin trousers, which she has described as a breakthrough for stroke patients alike. By stimulating her paralysed leg through electrodes controlled by artificial intelligence, [...]

Mable set for further growth after investment in its gamified approach to speech and language therapy and counselling

According to researchers, a new low cost method for stroke rehabilitation at home could soon be available. This new low cost, portable brain-computer interface that connects the brain of stroke patients to powered exoskeletons for rehabilitation purposes has been validated and tested at the University of Houston. Professor Jose Luis Contreras-Vidal, Hugh Roy and Lillie [...]

Occupational therapist Lauren Edwards shares recommendations for investing in the right technology for your practice

A new groundbreaking app presented at the Society of NeuroInterventional Surgery’s 20th Annual Meeting, reveals how machine learning can be used to detect physical signs of stroke. Researchers at the UCLA David Geffen School of Medicine and several medical institutions in Bulgaria collaborated on a study titled “Smartphone-Enabled Machine Learning Algorithms for Autonomous Stroke Detection.” [...]

New experimental technology is showing early signs of having life transforming capabilities for those living with paralysis. This experimental technology, Brain-computer interface (BCI), makes it possible to move robotic limbs using only your thoughts. However, before BCI can make the transition from the lab to patients’ everyday lives, the problem of how to coax the [...]

Largest-ever clinical trial reveals symptoms disappeared in ten weeks for 56 per cent of participants